In this Key Insights activity, Drs. Morton Coleman and Ruben Niesvizky discuss highlights of the first day of Lymphoma & Myeloma 2017: An International Congress on Hematologic Malignancies held in October. Topics of discussion were focused on best practices and emerging data regarding myeloma management, including: measuring minimal residual disease; current and investigational regimens for indication, consolidation, and maintenance; outcomes with the addition of monoclonal antibodies; and the role of CAR-T therapy.
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?specialty=Hematology
© 2017 Imedex, LLC.